✦ LIBER ✦

Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors

✍ Scribed by Christian Thomas; Latif A. Wafa; Francois Lamoureux; Helen Cheng; Ladan Fazli; Martin E. Gleave; Paul S. Rennie

Book ID: 112179567
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 703 KB
Volume: 72
Category: Article
ISSN: 0270-4137
DOI: 10.1002/pros.21490

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

606 CARBIDOPA ENHANCES ANTITUMORAL ACTIV

606 CARBIDOPA ENHANCES ANTITUMORAL ACTIVITY OF BICALUTAMIDE ON THE ANDROGEN RECEPTOR-AXIS IN CASTRATION-RESISTANT PROSTATE TUMORS

✍ Thomas, Christian; Wafa, Latif; Lamoureux, Francois; Rennie, Paul S.; Gleave, Ma 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 42 KB

236 The combination of carbidopa plus bi

236 The combination of carbidopa plus bicalutamide suppresses androgen-receptor transactivation, induces apoptosis and delays castration-resistant prostate cancer progression

✍ C. Thomas; L.A. Wafa; F. Lamoureux; H. Cheng; L. Fazli; M.E. Gleave; P.S. Rennie 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 16 KB

MP-03.04 The Combination Treatment of Bi

MP-03.04 The Combination Treatment of Bicalutamide Plus Carbidopa Significantly Enhances the in vivo Antitumor Activity on LNCaP Castration-resistant Prostate Cancer Xenograft Tumors Compared To Single Use of Each Drug

✍ C. Thomas; L. Wafa; F. Lamoureux; L. Fazli; P. Rennie; M. Gleave 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Targeted disruption of the p160 coactiva

Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells

✍ Nakka, Manjula; Agoulnik, Irina U.; Weigel, Nancy L. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 873 KB

Commentary on “The E3 ubiquitin ligase S

Commentary on “The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.” Qi J, Tripathi M, Mishra R, Sahgal N, Fazli L, Ettinger S, Placzek WJ, Claps G, Chung LW, Bowtell D, Gleave M, Bhowmick N, Ronai ZA, Signal Transduction Program, Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.

✍ Olumi, Aria F. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB